Skip to content
Screener

LivaNova LIVN Treasury stock, shares (in shares)

Treasury stock, shares (in shares) at other companies

Artivion logo
ArtivionAORT
$1.49M0.0%
ICU Medical logo
ICU MedicalICUI
$179.64K+417,660%
ITG
Integer HoldingsITGR
CONMED logo
CONMEDCNMD
Boston Scientific logo
Boston ScientificBSX
ResMed logo
ResMedRMD

Other financials

Income statement

See full
Revenue$390.6M+10.8%
Gross profit$273.7M+14.5%
Operating income$49.5M-8.7%
Net income$108.6M+300%
EPS (diluted)$1.93+286%

Balance sheet

See full
Cash & equivalents$516.6M-13.0%
Total debt$348.5M-27.8%
Total equity$1.3B+18.0%
Total assets$2.6B+5.4%

Cash flow

See full
Operating cash flow$66.6M+5.8%
CapEx$31.6M+108%
Free cash flow$35.0M-26.7%

Valuation

See full
Market cap$4.21B+55.7%
Enterprise value$4.05B+55.9%
P/E22.8×-68.5×
P/S2.9×+0.8×

Profitability

See full
Gross margin68.1%+0.1pp
Operating margin12.7%-0.7pp
Net margin-16.1%-18.0pp
FCF margin10.1%-2.3pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.2×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.

The source filing: LivaNova’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 2:23 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001639691-26-000090
Line itemJune 30, 2026December 31, 2025
Shareholders’ Equity:
Ordinary Shares, £1.00 par value: Unlimited shares authorized; 55,601,145 shares issued and 55,051,768 shares outstanding as of June 30, 2026; 55,535,181 shares issued and 54,649,085 shares outstanding as of December 31, 202584,59984,564
Additional paid-in capital2,270,6992,254,980
Accumulated other comprehensive (loss) income(14,386)7,330
Accumulated deficit(1,014,858)(1,145,721)
Treasury shares at cost, 549,377 ordinary shares as of June 30, 2026; 886,096 ordinary shares as of December 31, 2025(732)(1,166)
Total Shareholders’ Equity1,325,3221,199,987
Total Liabilities and Shareholders’ Equity$2,640,861$2,606,053

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is LivaNova's treasury stock, shares (in shares)?
LivaNova (LIVN) reported treasury stock, shares (in shares) of $549.38K in Q2 2026.
How has LivaNova's treasury stock, shares (in shares) changed year-over-year?
LivaNova's treasury stock, shares (in shares) decreased by 39.5% year-over-year, from $908.44K to $549.38K.
What is the long-term trend for LivaNova's treasury stock, shares (in shares)?
Over 4 years (2021 to 2025), LivaNova's treasury stock, shares (in shares) has grown at a 15.5% compound annual growth rate (CAGR), from $498.21K to $886.1K.
What does treasury stock, shares (in shares) mean?
Treasury stock, shares (in shares)

Ask your AI about LivaNova's treasury stock, shares (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude